It's easier now to treat opioid addiction with medication--but use has changed little
Abrupt policy shift removed a unique barrier to prescribing buprenorphine, but didn’t lead to a sharp rise in prescribing by the end of the first year
We're still accepting applications for fall 2024!
Apply TodayAbrupt policy shift removed a unique barrier to prescribing buprenorphine, but didn’t lead to a sharp rise in prescribing by the end of the first year
Five-year trend study shows rebound in inappropriate use after an early-pandemic dip, and a need to tackle overuse in all patients during viral illness outbreaks.
Worries that surgery patients would have a tougher recovery if their doctors had to abide by a five-day limit on opioid pain medication prescriptions didn’t play out as expected, a new study finds.
David Hutton, a professor of Health Management and Policy and Global Public Health, discusses the cost-effectiveness of RSV vaccination in older adults. Hutton and a group of University of Michigan researchers recently presented research on the topic during a meeting for the CDC's Advisory Committee on Immunization Practices (ACIP).
Biostatistics expert Peter Song and team have created a tool to assess the effectiveness of preventive measures in the fight against the COVID-19, still a new disease with many unknowns. The model lets us compare the impact of different levels of intervention so different locales can develop better strategies and policies to flatten the coronavirus curve.
Broad distribution of the opioid reversal drug naloxone is highly cost-effective in reducing fatal overdoses, according to a new University of Michigan study.